These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 26461089)
21. A starring role for stellate cells in the pancreatic cancer microenvironment. Apte MV; Wilson JS; Lugea A; Pandol SJ Gastroenterology; 2013 Jun; 144(6):1210-9. PubMed ID: 23622130 [TBL] [Abstract][Full Text] [Related]
23. Stromal biology and therapy in pancreatic cancer: ready for clinical translation? Neesse A; Bauer CA; Öhlund D; Lauth M; Buchholz M; Michl P; Tuveson DA; Gress TM Gut; 2019 Jan; 68(1):159-171. PubMed ID: 30177543 [TBL] [Abstract][Full Text] [Related]
24. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma. Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030 [TBL] [Abstract][Full Text] [Related]
25. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications. Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007 [TBL] [Abstract][Full Text] [Related]
26. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mahadevan D; Von Hoff DD Mol Cancer Ther; 2007 Apr; 6(4):1186-97. PubMed ID: 17406031 [TBL] [Abstract][Full Text] [Related]
27. Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells. Fabian A; Stegner S; Miarka L; Zimmermann J; Lenk L; Rahn S; Buttlar J; Viol F; Knaack H; Esser D; Schäuble S; Großmann P; Marinos G; Häsler R; Mikulits W; Saur D; Kaleta C; Schäfer H; Sebens S Cancer Lett; 2019 Jul; 453():95-106. PubMed ID: 30930235 [TBL] [Abstract][Full Text] [Related]
28. Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis. Drifka CR; Tod J; Loeffler AG; Liu Y; Thomas GJ; Eliceiri KW; Kao WJ Mod Pathol; 2015 Nov; 28(11):1470-80. PubMed ID: 26336888 [TBL] [Abstract][Full Text] [Related]
29. Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins. Liot S; Balas J; Aubert A; Prigent L; Mercier-Gouy P; Verrier B; Bertolino P; Hennino A; Valcourt U; Lambert E Front Immunol; 2021; 12():612271. PubMed ID: 33889150 [TBL] [Abstract][Full Text] [Related]
30. Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer. Galván JA; Zlobec I; Wartenberg M; Lugli A; Gloor B; Perren A; Karamitopoulou E Br J Cancer; 2015 Jun; 112(12):1944-50. PubMed ID: 25989272 [TBL] [Abstract][Full Text] [Related]
32. Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma. DuFort CC; DelGiorno KE; Hingorani SR Gastroenterology; 2016 Jun; 150(7):1545-1557.e2. PubMed ID: 27072672 [TBL] [Abstract][Full Text] [Related]
33. Stromal biology and therapy in pancreatic cancer: a changing paradigm. Neesse A; Algül H; Tuveson DA; Gress TM Gut; 2015 Sep; 64(9):1476-84. PubMed ID: 25994217 [TBL] [Abstract][Full Text] [Related]
34. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix. Jiang H; Torphy RJ; Steiger K; Hongo H; Ritchie AJ; Kriegsmann M; Horst D; Umetsu SE; Joseph NM; McGregor K; Pishvaian MJ; Blais EM; Lu B; Li M; Hollingsworth M; Stashko C; Volmar K; Yeh JJ; Weaver VM; Wang ZJ; Tempero MA; Weichert W; Collisson EA J Clin Invest; 2020 Sep; 130(9):4704-4709. PubMed ID: 32749238 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer. Whatcott CJ; Ng S; Barrett MT; Hostetter G; Von Hoff DD; Han H PLoS One; 2017; 12(8):e0183871. PubMed ID: 28841710 [TBL] [Abstract][Full Text] [Related]
36. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma. Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602 [TBL] [Abstract][Full Text] [Related]
37. Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer. Zambirinis CP; Miller G Trends Mol Med; 2017 May; 23(5):465-481. PubMed ID: 28400243 [TBL] [Abstract][Full Text] [Related]
38. The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians. Klöppel G; Lüttges J Curr Gastroenterol Rep; 2004 Apr; 6(2):111-8. PubMed ID: 15191688 [TBL] [Abstract][Full Text] [Related]
39. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer. Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562 [TBL] [Abstract][Full Text] [Related]
40. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Yamaguchi K; Kanemitsu S; Hatori T; Maguchi H; Shimizu Y; Tada M; Nakagohri T; Hanada K; Osanai M; Noda Y; Nakaizumi A; Furukawa T; Ban S; Nobukawa B; Kato Y; Tanaka M Pancreas; 2011 May; 40(4):571-80. PubMed ID: 21499212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]